Skip to main content
SpringerLink
Log in

Extending government-insured DR screening cost effective in Canada

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • van Katwyk S, et al. Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists. Value in Health : 1 Jun 2017. Available from: URL: https://doi.org/10.1016/j.jval.2017.04.015

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Extending government-insured DR screening cost effective in Canada. PharmacoEcon Outcomes News 780, 16 (2017). https://doi.org/10.1007/s40274-017-4068-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4068-7

Search

Navigation